Remove 2007 Remove Compounding Remove Vaccines
article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

pharmaphorum

US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers with leftover stock – is branching out into antivirals with the help of an $8 million fundraising. The post Dr B raises $8m for telehealth service to deliver COVID antivirals appeared first on.

article thumbnail

A history of Pfizer

pharmaphorum

It was at this time they set their site at Sandwich in the UK, initially just to finish processing compounds imported from America, but due to tariffs on imported products the company rapidly expanded the plant to accommodate producing medicines from scratch. Likewise, tanezumab, an anti-osteoarthritic, failed in trials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

Microbial Contaminants From 2007 to 2021, 90 cases of contamination due to microorganisms were reported, with 61 caused by bacteria, 5 , 6 , 7 , 8 , 9 , 10 , 23 by viruses, 11 , 12 and 6 by fungi. 5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. And all are predominantly prevented or treated with medicines that are decades old.

FDA 98
article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

article thumbnail

Beating the Big C

Pharmaceutical Technology

Demand for treatment The American Cancer Society estimates that over 12 million new cancer cases were diagnosed worldwide in 2007. “You can get vaccines now to prevent cervical cancer. And are we getting any closer to beating the Big C? “For certain cancers, yes,” says Ando.

article thumbnail

Getting on with Rare Disease Therapeutic Options (Orphan Disease Therapies)

PharmaShots

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. In late 2007, both FDA and EMA came to a mutual understanding of using a common application process with a distinct approval process, making it easier for manufacturers to apply for orphan drug status.

FDA 40